Connection

Zahra Ahmadinejad to Sofosbuvir

Back to Details
This is a "connection" page, showing publications Zahra Ahmadinejad has written about Sofosbuvir.
Zahra Ahmadinejad
Connection Strength
0.151
Sofosbuvir
  1. Efficacy and safety of sofosbuvir/ ledipasvir in treatment of patients with COVID-19; A randomized clinical trial. Acta Biomed. 2020 11 10; 91(4):e2020102.
    View in: PubMed
    Score: 0.151
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.